EV/EBIT Ratio: 37.86x
Is the EV/EBIT ratio high or low?
The EV/EBIT ratio of 37.86x is in line with its 5-year average of 34.98x, around the middle of its 5-year range (19.79x–59.00x).
As of Saturday, June 27, 2026. 25.63% above its 12-month average of 30.14x.
WST EV/EBIT Ratio Chart
WST Average EV/EBIT Ratio Chart
WST Current vs Average EV/EBIT Ratio Chart
WST EV/EBIT Ratio Metrics
EV/EBIT RATIO
37.86x
EV/EBIT RATIO AVG TTM
30.14x
EV/EBIT RATIO AVG 3Y
33.98x
EV/EBIT RATIO AVG 5Y
34.81x
EV/EBIT RATIO AVG 10Y
36.46x
EV/EBIT RATIO AVG 15Y
32.48x
EV/EBIT RATIO AVG 20Y
28.63x
CURRENT VS TTM AVG
+25.63%
CURRENT VS 3Y AVG
+11.41%
CURRENT VS 5Y AVG
+8.76%
CURRENT VS 10Y AVG
+3.83%
CURRENT VS 15Y AVG
+16.58%
CURRENT VS 20Y AVG
+32.23%
WST Competitors' EV/EBIT Ratio
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| West Pharmaceutical Services, Inc. (WST) | $24.79B | 37.86x | 30.14x | 33.98x | 34.81x |
| Waters Corporation (WAT)vs › | $24.41B | 55.69x | 28.79x | 26.99x | 26.44x |
| Mettler-Toledo International Inc. (MTD)vs › | $25.54B | 24.28x | 26.02x | 26.23x | 29.10x |
| Quest Diagnostics Incorporated (DGX)vs › | $23.08B | 18.39x | 17.88x | 17.63x | 14.72x |
| BioNTech SE (BNTX)vs › | $23.07B | N/A | 4.91x | 5.85x | 5.85x |
| United Therapeutics Corporation (UTHR)vs › | $23.03B | 17.08x | 14.06x | 11.94x | 13.30x |
| Moderna, Inc. (MRNA)vs › | $26.69B | N/A | 23.08x | 30.95x | 30.95x |
| Incyte Corporation (INCY)vs › | $22.73B | 13.86x | 18.20x | 111.32x | 74.85x |
| DexCom, Inc. (DXCM)vs › | $27.07B | 26.97x | 37.50x | 63.87x | 100.90x |
| Labcorp Holdings Inc. (LH)vs › | $22.26B | 18.44x | 21.69x | 26.24x | 19.69x |
EV/EBIT Ratio Formula & Definition
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
EV/EBIT Ratio FAQ
- What is the EV/EBIT ratio for West Pharmaceutical Services, Inc. (WST)?
- The EV/EBIT ratio for WST stock is 37.86x.
- Is West Pharmaceutical Services, Inc.'s EV/EBIT ratio high or low?
- The EV/EBIT ratio of 37.86x is in line with its 5-year average of 34.98x, around the middle of its 5-year range (19.79x–59.00x).
- What is the TTM average EV/EBIT ratio for West Pharmaceutical Services, Inc. (WST)?
- The TTM average EV/EBIT ratio for WST stock is 30.14x.
- What is the 3Y average EV/EBIT ratio for West Pharmaceutical Services, Inc. (WST)?
- The 3Y average EV/EBIT ratio for WST stock is 33.98x.
- What is the 5Y average EV/EBIT ratio for West Pharmaceutical Services, Inc. (WST)?
- The 5Y average EV/EBIT ratio for WST stock is 34.81x.
- What is the 10Y average EV/EBIT ratio for West Pharmaceutical Services, Inc. (WST)?
- The 10Y average EV/EBIT ratio for WST stock is 36.46x.
- What is the 15Y average EV/EBIT ratio for West Pharmaceutical Services, Inc. (WST)?
- The 15Y average EV/EBIT ratio for WST stock is 32.48x.
- What is the 20Y average EV/EBIT ratio for West Pharmaceutical Services, Inc. (WST)?
- The 20Y average EV/EBIT ratio for WST stock is 28.63x.
WST EV/EBIT Ratio History
| DATE | EV/EBIT RATIO |
|---|---|
| 2026-06-26 | 37.86x |
| 2026-06-25 | 37.39x |
| 2026-06-24 | 36.72x |
| 2026-06-23 | 36.28x |
| 2026-06-22 | 35.56x |
| 2026-06-18 | 35.36x |
| 2026-06-17 | 34.89x |
| 2026-06-16 | 35.54x |
| 2026-06-15 | 35.74x |
| 2026-06-12 | 35.46x |
| 2026-06-11 | 35.62x |
| 2026-06-10 | 35.69x |
| 2026-06-09 | 36.09x |
| 2026-06-08 | 34.47x |
| 2026-06-05 | 33.90x |
| 2026-06-04 | 34.21x |
| 2026-06-03 | 34.10x |
| 2026-06-02 | 33.65x |
| 2026-06-01 | 34.10x |
| 2026-05-29 | 34.81x |
| 2026-05-28 | 34.70x |
| 2026-05-27 | 33.71x |
| 2026-05-26 | 34.08x |
| 2026-05-22 | 34.11x |
| 2026-05-21 | 34.08x |
| 2026-05-20 | 32.92x |
| 2026-05-19 | 32.75x |
| 2026-05-18 | 32.80x |
| 2026-05-15 | 32.64x |
| 2026-05-14 | 32.34x |
| 2026-05-13 | 32.58x |
| 2026-05-12 | 33.64x |
| 2026-05-11 | 34.75x |
| 2026-05-08 | 35.14x |
| 2026-05-07 | 34.72x |
| 2026-05-06 | 33.69x |
| 2026-05-05 | 33.41x |
| 2026-05-04 | 32.34x |
| 2026-05-01 | 32.40x |
| 2026-04-30 | 32.06x |
| 2026-04-29 | 31.82x |
| 2026-04-28 | 31.47x |
| 2026-04-27 | 32.56x |
| 2026-04-24 | 32.99x |
| 2026-04-23 | 33.38x |
| 2026-04-22 | 31.58x |
| 2026-04-21 | 31.61x |
| 2026-04-20 | 32.00x |
| 2026-04-17 | 31.50x |
| 2026-04-16 | 31.03x |
| 2026-04-15 | 30.64x |
| 2026-04-14 | 30.81x |
| 2026-04-13 | 29.87x |
| 2026-04-10 | 29.47x |
| 2026-04-09 | 29.71x |
| 2026-04-08 | 30.58x |
| 2026-04-07 | 29.80x |
| 2026-04-06 | 29.51x |
| 2026-04-02 | 29.27x |
| 2026-04-01 | 29.02x |
| 2026-03-31 | 28.78x |
| 2026-03-30 | 28.13x |
| 2026-03-27 | 27.92x |
| 2026-03-26 | 28.48x |
| 2026-03-25 | 28.35x |
| 2026-03-24 | 28.14x |
| 2026-03-23 | 27.69x |
| 2026-03-20 | 27.17x |
| 2026-03-19 | 27.56x |
| 2026-03-18 | 27.40x |
| 2026-03-17 | 27.45x |
| 2026-03-16 | 27.56x |
| 2026-03-13 | 26.99x |
| 2026-03-12 | 26.47x |
| 2026-03-11 | 27.31x |
| 2026-03-10 | 26.79x |
| 2026-03-09 | 28.47x |
| 2026-03-06 | 28.21x |
| 2026-03-05 | 28.03x |
| 2026-03-04 | 28.56x |
| 2026-03-03 | 28.86x |
| 2026-03-02 | 28.85x |
| 2026-02-27 | 29.21x |
| 2026-02-26 | 28.58x |
| 2026-02-25 | 28.45x |
| 2026-02-24 | 28.16x |
| 2026-02-23 | 28.02x |
| 2026-02-20 | 27.65x |
| 2026-02-19 | 27.97x |
| 2026-02-18 | 28.49x |
| 2026-02-17 | 27.90x |
| 2026-02-13 | 28.34x |
| 2026-02-12 | 27.55x |
| 2026-02-11 | 27.84x |
| 2026-02-10 | 27.54x |
| 2026-02-09 | 28.16x |
| 2026-02-06 | 28.16x |
| 2026-02-05 | 26.17x |
| 2026-02-04 | 26.79x |
| 2026-02-03 | 26.09x |
| 2026-02-02 | 26.84x |
| 2026-01-30 | 26.11x |
| 2026-01-29 | 26.28x |
| 2026-01-28 | 26.66x |
| 2026-01-27 | 27.19x |
| 2026-01-26 | 27.29x |
| 2026-01-23 | 26.75x |
| 2026-01-22 | 28.03x |
| 2026-01-21 | 28.88x |
| 2026-01-20 | 28.34x |
| 2026-01-16 | 29.41x |
| 2026-01-15 | 31.67x |
| 2026-01-14 | 31.16x |
| 2026-01-13 | 30.80x |
| 2026-01-12 | 30.92x |
| 2026-01-09 | 31.22x |
| 2026-01-08 | 31.19x |
| 2026-01-07 | 31.56x |
| 2026-01-06 | 31.82x |
| 2026-01-05 | 31.63x |
| 2026-01-02 | 31.33x |
| 2025-12-31 | 31.18x |
| 2025-12-30 | 31.38x |
| 2025-12-29 | 31.23x |
| 2025-12-26 | 31.08x |
| 2025-12-24 | 31.36x |
| 2025-12-23 | 31.45x |
| 2025-12-22 | 31.15x |
| 2025-12-19 | 30.88x |
| 2025-12-18 | 30.43x |
| 2025-12-17 | 30.49x |
| 2025-12-16 | 30.18x |
| 2025-12-15 | 30.80x |
| 2025-12-12 | 30.31x |
| 2025-12-11 | 30.88x |
| 2025-12-10 | 30.24x |
| 2025-12-09 | 30.14x |
| 2025-12-08 | 30.48x |
| 2025-12-05 | 31.77x |
| 2025-12-04 | 31.94x |
| 2025-12-03 | 32.24x |
| 2025-12-02 | 30.94x |
| 2025-12-01 | 31.07x |
| 2025-11-28 | 31.42x |
| 2025-11-26 | 31.41x |
| 2025-11-25 | 31.84x |
| 2025-11-24 | 31.05x |
| 2025-11-21 | 30.71x |
| 2025-11-20 | 29.18x |
| 2025-11-19 | 29.19x |
| 2025-11-18 | 29.45x |
| 2025-11-17 | 29.71x |
| 2025-11-14 | 29.59x |
| 2025-11-13 | 30.20x |
| 2025-11-12 | 31.03x |
| 2025-11-11 | 31.44x |
| 2025-11-10 | 31.22x |
| 2025-11-07 | 30.71x |
| 2025-11-06 | 31.20x |
| 2025-11-05 | 32.15x |
| 2025-11-04 | 32.54x |
| 2025-11-03 | 31.72x |
| 2025-10-31 | 31.98x |
| 2025-10-30 | 31.57x |
| 2025-10-29 | 32.30x |
| 2025-10-28 | 32.14x |
| 2025-10-27 | 32.57x |
| 2025-10-24 | 33.75x |
| 2025-10-23 | 34.88x |
| 2025-10-22 | 31.93x |
| 2025-10-21 | 32.21x |
| 2025-10-20 | 31.69x |
| 2025-10-17 | 31.19x |
| 2025-10-16 | 30.79x |
| 2025-10-15 | 30.30x |
| 2025-10-14 | 30.09x |
| 2025-10-13 | 30.24x |
| 2025-10-10 | 30.16x |
| 2025-10-09 | 30.37x |
| 2025-10-08 | 30.88x |
| 2025-10-07 | 30.65x |
| 2025-10-06 | 30.89x |
| 2025-10-03 | 31.42x |
| 2025-10-02 | 31.49x |
| 2025-10-01 | 31.28x |
| 2025-09-30 | 30.23x |
| 2025-09-29 | 29.99x |
| 2025-09-26 | 30.13x |
| 2025-09-25 | 29.31x |
| 2025-09-24 | 29.95x |
| 2025-09-23 | 28.88x |
| 2025-09-22 | 29.05x |
| 2025-09-19 | 29.35x |
| 2025-09-18 | 29.37x |
| 2025-09-17 | 29.56x |
| 2025-09-16 | 29.76x |
| 2025-09-15 | 29.67x |
| 2025-09-12 | 29.20x |
| 2025-09-11 | 30.39x |
| 2025-09-10 | 29.40x |
| 2025-09-09 | 29.03x |
| 2025-09-08 | 29.16x |
| 2025-09-05 | 28.87x |
| 2025-09-04 | 28.50x |
| 2025-09-03 | 28.67x |
| 2025-09-02 | 28.06x |
| 2025-08-29 | 28.43x |
| 2025-08-28 | 28.26x |
| 2025-08-27 | 28.32x |
| 2025-08-26 | 28.15x |
| 2025-08-25 | 28.46x |
| 2025-08-22 | 28.54x |
| 2025-08-21 | 27.93x |
| 2025-08-20 | 28.37x |
| 2025-08-19 | 28.44x |
| 2025-08-18 | 27.98x |
| 2025-08-15 | 28.35x |
| 2025-08-14 | 28.35x |
| 2025-08-13 | 28.35x |
| 2025-08-12 | 27.61x |
| 2025-08-11 | 27.66x |
| 2025-08-08 | 27.74x |
| 2025-08-07 | 27.69x |
| 2025-08-06 | 27.31x |
| 2025-08-05 | 27.49x |
| 2025-08-04 | 27.44x |
| 2025-08-01 | 27.54x |
| 2025-07-31 | 27.54x |
| 2025-07-30 | 28.70x |
| 2025-07-29 | 29.13x |
| 2025-07-28 | 29.69x |
| 2025-07-25 | 30.36x |
| 2025-07-24 | 32.18x |
| 2025-07-23 | 27.60x |
| 2025-07-22 | 26.57x |
| 2025-07-21 | 25.49x |
| 2025-07-18 | 25.59x |
| 2025-07-17 | 26.90x |
| 2025-07-16 | 27.24x |
| 2025-07-15 | 26.83x |
| 2025-07-14 | 27.25x |
| 2025-07-11 | 27.58x |
| 2025-07-10 | 27.83x |
| 2025-07-09 | 27.46x |
| 2025-07-08 | 26.76x |
| 2025-07-07 | 26.89x |
| 2025-07-03 | 26.98x |
| 2025-07-02 | 26.85x |
| 2025-07-01 | 27.00x |
| 2025-06-30 | 26.56x |
| 2025-06-27 | 26.57x |
| 2025-06-26 | 26.58x |
| 2025-06-25 | 26.83x |
| 2025-06-24 | 27.03x |
| 2025-06-23 | 26.30x |
| 2025-06-20 | 26.19x |
| 2025-06-18 | 26.45x |
| 2025-06-17 | 26.47x |
| 2025-06-16 | 27.23x |
| 2025-06-13 | 26.94x |
Showing the most recent 260 of 5,032 data points. The chart above shows the full history.
Related Metrics
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Eric Green